Citeline：2024科技与趋势报告（英文版）（30页）.pdf

1、Look AheadTech&Trends 2024A look ahead at some of the most exciting innovations and movements that are changing the industry as we know it.Sponsored by2December 2023 Copyright 2023 Pharma Intelligence UK Limited,a Citeline company(Unauthorized photocopying prohibited)Foreword and ContentsThe State O

2、f TechBio Going Into 2024 03How Boehringer,Lilly Are Taming The GenAI Dragon For Regulatory,Commercial Content 08Life Sciences Scaling Adoption Of New Metaverse,AI Tools 12What Next In Oncology?17The Power Of AI To Map The Patient Journey 23Step into the future of healthcare as we explore the key in

3、novations shaping our industry in 2024 and beyond.Read on as we discover how members of the Techbio community are already utilizing artificial intelligence(AI)to boost drug discovery and maximise clinical trial success.Next,leaders at Boehringer and Eli Lilly reveal how Open AIs GPT-4 is transformin

4、g regulatory and commercial content,helping overcome challenges and securing executive support.With more companies embracing newer digital technologies,we ask if 2024 will be the turning point for the adoption of metaverse,augmented and virtual reality applications.Then while the search for the next

5、 blockbuster drug unfolds,delve into the challenges and opportunities in oncology which still dominates the pharma sales and pipeline league tables.Conclude your journey by taking a look into the transformative power of AI in mapping the patient journey,and provide insights into current clinical pat

6、hways and the potential for predictive interventions.Embark on this exploration of 2024,where collaboration,innovation,and technology converge to shape a future marked by improved patient outcomes and enhanced healthcare experiences.3January 2023 Copyright 2023 Pharma Intelligence UK Limited,a Citel